Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

38.75p
   
  • Change Today:
      0.50p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.39m
  • Volume: 305,470
  • Market Cap: 209.40m
  • RiskGrade: 119
  • Beta: 0.74

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.6% 0.0%
Div Cover 2.4 3.0
Op Mrgn 6.3% 23.1%
ROCE 16.2%  
Latest F'cast
P/E 9.1 8.6
PEG n/a 1.6
Pr/Revenue 1.3 1.1
Pr/Book 0.7  
Latest F'cast
Revenue 2.6% 9.1%
PBT -71.3% 709.6%
EPS -33.0% 5.4%
DPS 5.0% -16.1%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 5.21 4.28p 12.4 n/a -33% 1.78p 3.4%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 182.73 42.16 4.51p 8.6 1.6 +5% 1.49p 0.0%
31-Dec-24 198.24 46.93 5.40p 7.2 0.4 +20% 1.51p 0.0%
31-Dec-25 215.91 52.22 6.42p 6.0 0.3 +19% 1.57p 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Total Voting Rights 01-Dec-2023 12:23 RNS
Notification of Major Holdings 09-Nov-2023 11:17 RNS
Appointment of Non-Executive Directors 07-Nov-2023 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 38.75p
Change Today 0.50p
% Change 1.31 %
52 Week High 71.80
52 Week Low 34.50
Volume 305,470
Shares Issued 540.39m
Market Cap 209.40m
Beta 0.74
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.50% above the market average86.50% above the market average86.50% above the market average86.50% above the market average86.50% above the market average
96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average
Price Trend
60.2% below the market average60.2% below the market average60.2% below the market average60.2% below the market average60.2% below the market average
5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average
Income
45.86% above the market average45.86% above the market average45.86% above the market average45.86% above the market average45.86% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
90.71% below the market average90.71% below the market average90.71% below the market average90.71% below the market average90.71% below the market average
94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 08-Dec-2023

Time Volume / Share Price
16:35 34,163 @ 38.75p
16:35 379 @ 38.75p
16:35 379 @ 38.75p
16:35 94 @ 38.75p
16:35 282 @ 38.75p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Jo Le Couilliard

Top of Page